A highly relevant study showed increases in the expression of TET2 and 5hmC in a number of cancers that modulated the expression of TNF-α signalling components and facilitated chemotherapy resistance in slow-cycling cancer cells by restraining proapoptotic signalling [24]. The gene discussed is TET2; the disease is cancer.